Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Wodarz

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Cancer Research|April 6, 2021
Adaptive Therapy and the Cost of Drug-Resistant MutantsDominik Wodarz
Journal of Theoretical Biology|December 21, 2006
Effect of stem cell turnover rates on protection against cancer and agingDominik Wodarz
Proceedings. Biological Sciences|February 12, 2010
Heterogeneity in chronic myeloid leukaemia dynamics during imatinib treatment: role of immune responsesDominik Wodarz
Nature Medicine|October 2, 2003
Mutants escape from killer T cells, invade populationDominik Wodarz
Current Biology : CB|September 19, 2003
Evolution of immunological memory and the regulation of competition between pathogensDominik Wodarz
Human Gene Therapy|March 5, 2003
Gene therapy for killing p53-negative cancer cells: use of replicating versus nonreplicating agentsDominik Wodarz
Cancer Research|December 18, 2003
Correspondence re: L. M. Wein et al., validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. Cancer Res., 63: 1317-1324, 2003Dominik Wodarz
Theoretical Population Biology|May 15, 2007
On the relative fitness of early and late stage Simian immunodeficiency virus isolatesDominik Wodarz
Ecology Letters|May 19, 2006
Ecological and evolutionary principles in immunologyDominik Wodarz
Oncogene|September 14, 2004
Checkpoint genes, ageing, and the development of cancerDominik Wodarz
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Cancer Research|April 6, 2021
Adaptive Therapy and the Cost of Drug-Resistant MutantsDominik Wodarz
Journal of Theoretical Biology|December 21, 2006
Effect of stem cell turnover rates on protection against cancer and agingDominik Wodarz
Proceedings. Biological Sciences|February 12, 2010
Heterogeneity in chronic myeloid leukaemia dynamics during imatinib treatment: role of immune responsesDominik Wodarz
Nature Medicine|October 2, 2003
Mutants escape from killer T cells, invade populationDominik Wodarz
Current Biology : CB|September 19, 2003
Evolution of immunological memory and the regulation of competition between pathogensDominik Wodarz
Human Gene Therapy|March 5, 2003
Gene therapy for killing p53-negative cancer cells: use of replicating versus nonreplicating agentsDominik Wodarz
Cancer Research|December 18, 2003
Correspondence re: L. M. Wein et al., validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. Cancer Res., 63: 1317-1324, 2003Dominik Wodarz
Theoretical Population Biology|May 15, 2007
On the relative fitness of early and late stage Simian immunodeficiency virus isolatesDominik Wodarz
Ecology Letters|May 19, 2006
Ecological and evolutionary principles in immunologyDominik Wodarz
Oncogene|September 14, 2004
Checkpoint genes, ageing, and the development of cancerDominik Wodarz
Pageof 14